--- title: "4568.JP (4568.JP) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/4568.JP/news.md" symbol: "4568.JP" name: "4568.JP" parent: "https://longbridge.com/en/quote/4568.JP.md" datetime: "2026-05-20T22:36:08.412Z" locales: - [en](https://longbridge.com/en/quote/4568.JP/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/4568.JP/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/4568.JP/news.md) --- # 4568.JP (4568.JP) — Related News ### [FDA approves Enhertu for two HER2-positive early breast cancer indications](https://longbridge.com/en/news/286740066.md) *2026-05-18T07:49:17.000Z* > A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. ### [](https://longbridge.com/en/news/286780814.md) *2026-05-18T13:11:58.000Z* > The FDA has expanded the use of Enhertu (trastuzumab deruxtecan) for HER2-positive Stage II and III breast cancer, appro ### [Daiichi Sankyo Earnings Fall; Guides FY27](https://longbridge.com/en/news/285895666.md) *2026-05-11T07:07:26.000Z* > Daiichi Sankyo Co. Ltd. reported a 12.1% decline in net income for the fiscal year ending March 31, 2026, with profit at ### [Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation](https://longbridge.com/en/news/285893113.md) *2026-05-11T06:45:24.000Z* > Daiichi Sankyo has unveiled a new Five-Year Business Plan (FY2026 - FY2030) aimed at achieving over 2.3 trillion yen in ### [Daiichi Sankyo and Waiv partner for ADC biomarkers](https://longbridge.com/en/news/285532705.md) *2026-05-07T09:03:01.000Z* > A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. ### [](https://longbridge.com/en/news/285484060.md) *2026-05-07T04:32:48.000Z* > Daiichi Sankyo Healthcare in Japan plans to raise drug prices, with the maximum increase reaching 40% ### [Shares of Japanese Drugmaker Daiichi Sankyo Tumble on Delay in Earnings](https://longbridge.com/en/news/283937672.md) *2026-04-24T05:20:34.000Z* > Shares of Daiichi Sankyo fell nearly 11% to 2,497.50 yen after the company delayed its earnings report for the fiscal ye ### [](https://longbridge.com/en/news/283918525.md) *2026-04-24T01:46:12.000Z* > Daiichi Sankyo's stock price fell by 10% after delaying the release of its annual financial report